This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Disease Info Card
Hypertrophic Cardiomyopathy
Information about Hypertrophic Cardiomyopathy: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Hypertrophic Cardiomyopathy
Most recent studies have shown that Hypertrophic Cardiomyopathy shares some biological mechanisms with aortic-valve-stenosis, cardiac-arrhythmia, cardiac-death, cardiomyopathies, cardiomyopathy-dilated, cardiomyopathy-hypertrophic-familial, coronary-heart-disease, heart-diseases, heart-failure, hypertensive-disease, hypertrophy, idiopathic-hypertrophic-subaortic-stenosis, left-ventricular-hypertrophy, mitral-valve-insufficiency, myocardial-infarction, stenosis, subaortic-stenosis, sudden-cardiac-death, sudden-death.
Among the many pathways, these few ones have gauged particular interests from scientists studying Hypertrophic Cardiomyopathy, and have been seen in publications frequently: Aging, Cardiac Conduction, Cardiac Muscle Contraction, Cell Death, Coagulation, Excretion, Fatty Acid Oxidation, Innervation, Localization, Muscle Contraction, Muscle Hypertrophy, Oxidative Phosphorylation, Pathogenesis, Reflex, Secretion, Swimming, Translation, Transport, Transposition, Vasodilation
Quite a number of genes have been found to play important roles in Hypertrophic Cardiomyopathy, such as ACE, AGT, FTH1, GNL3, KRAS, KRT5, LDLR, MYBPC3, MYH14, MYH7, PTPN11, TNNI3, TNNT2, TPM1, TTN. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.